| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $124K | -3.9% |
| SG&A Expense | $1.4M | -31.3% |
| Operating Income | -$1.6M | +24.2% |
| Pre-tax Income | -$1.8M | -39.3% |
| Net Income | -$1.8M | -39.3% |
| EPS (Basic) | -$0.01 | -40.0% |
| EPS (Diluted) | -$0.01 | -40.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $222K | +270.0% |
| Inventory | $14K | — |
| Current Assets | $278K | +251.9% |
| Total Assets | $474K | +131.2% |
| Total Liabilities | $3.0M | +9.4% |
| Stockholders' Equity | -$2.5M | +0.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$597K | -0.3% |
| Investing Cash Flow | -$93K | — |
| Financing Cash Flow | $865K | +95.7% |